Therapeutic Expertise
We have experience in various phases of clinical trials, real-world studies, and wide therapeutic areas.
Therapeutic Focus
Therapeutic Expertise
ONCOLOGY
Cytogenex has extensive experience supporting oncology publication programs across multiple tumor types and treatment modalities. We support publications from early-phase clinical studies through large Phase III trials and post-marketing real-world studies. Our oncology writers understand complex study designs, survival analyses, and biomarker-driven therapies.
Tumor Types Supported
- Lung cancer (NSCLC and SCLC)
- Breast cancer
- Colorectal cancer
- Gastric cancer
- Liver cancer
- Pancreatic cancer
- Prostate cancer
- Ovarian cancer
- Cervical cancer
- Renal cell carcinoma
- Melanoma
- Leukemia
- Lymphoma
- Multiple myeloma
Treatment Modalities
- Immunotherapy
- Targeted therapies
- Chemotherapy
- Hormonal therapies
- Combination therapies
- CAR-T therapies
- Biosimilars
Scientific Expertise
- Survival analysis (OS, PFS, DFS)
- Biomarker studies
- Companion diagnostics
- Subgroup analyses
- Safety data interpretation
- Benefit-risk assessment
Publications Supported
- Phase I–III trial manuscripts
- Real-world evidence manuscripts
- Review articles
- Meta-analyses
- Conference abstracts
- Posters
Core Therapeutic Areas
Our deep domain expertise across major therapeutic areas ensures predictive, precise, and reliable outcomes for your scientific publications.